This IDC study is the third of a three-part life science R&D IDC MarketScape series focused on IT outsourcing. With a specific focus on strategic consulting in the life science R&D space, this study seeks to compare major service providers with each other based on criteria that should be important to life science companies when considering the selection of a strategic consulting partner to help provide guidance for strategic, operational, and tactical transformation issues within the R&D space.
Alan Louie, research director of IDC Health Insights' Clinical Development, Strategy and Technology research, noted, "Strategic consulting in the life sciences is more important than ever as industry transformation moves forward. Beyond smoothing transitions and optimizing operational and business performance, companies are actively breaking new ground and extending their world view. Partner ecosystems are increasingly capable of delivering the complete process life cycle and have become a critical component of life science corporate strategies for success. The selection of an optimal partner ecosystem is key to developing and executing these increasingly externalized complex business strategies. IDC expects that the dependence on external service providers will continue to grow as organizations seek to navigate through increasingly complex global, regulatory, and operational life science ecosystems. Leading vendors as preferred partners that understand their sponsor's business almost as well as their sponsors and have the capacity to deliver superior services will be key to helping their clients succeed, both now and in the future."
Deloitte, Wipro Limited, Cognizant Technology Solutions Corporation, Accenture plc, McKinsey & Company, iGate Corporation, The Boston Consulting Group, Inc., Indegene Lifesystems Pvt Ltd., HCL, IBM, Tata Group, PricewaterhouseCoopers LLP, Infosys Limited